Suppr超能文献

GM2 神经节苷脂贮积症成年患者的自然病史。

Natural History of Adult Patients with GM2 Gangliosidosis.

机构信息

Reference Center for Neuromuscular Disorders Nord/Est/Île-de-France, Institute of Myology, Pitié-Salpêtrière University Hospital Group (Assistance publique Hôpitaux de Paris (AP-HP)), Paris.

Department of Neurology, Reference Center for Lysosomal Diseases, Neuro-Genetic and Metabolism Unit, Pitié-Salpêtrière University Hospital Group (Assistance publique Hôpitaux de Paris (AP-HP)), Paris.

出版信息

Ann Neurol. 2020 Apr;87(4):609-617. doi: 10.1002/ana.25689. Epub 2020 Feb 7.

Abstract

OBJECTIVE

GM2 gangliosidoses are lysosomal diseases due to biallelic mutations in the HEXA (Tay-Sachs disease [TS]) or HEXB (Sandhoff disease [SD]) genes, with subsequent low hexosaminidase(s) activity. Most patients have childhood onset, but some experience the first symptoms during adolescence/adulthood. This study aims to clarify the natural history of adult patients with GM2 gangliosidosis.

METHODS

We retrospectively described 12 patients from a French cohort and 45 patients from the literature.

RESULTS

We observed 4 typical presentations: (1) lower motoneuron disorder responsible for proximal lower limb weakness that subsequently expanded to the upper limbs, (2) cerebellar ataxia, (3) psychosis and/or severe mood disorder (only in the TS patients), and (4) a complex phenotype mixing the above 3 manifestations. The psoas was the first and most affected muscle in the lower limbs, whereas the triceps and interosseous were predominantly involved in the upper limbs. A longitudinal study of compound motor action potentials showed a progressive decrease in all nerves, with different kinetics. Sensory potentials were sometimes abnormally low, mainly in the SD patients. The main brain magnetic resonance imaging feature was cerebellar atrophy, even in patients without cerebellar symptoms. The prognosis was mainly related to gait disorder, as we showed that beyond 20 years of disease evolution, half of the patients were wheelchair users.

INTERPRETATION

Improved knowledge of GM2 gangliosidosis in adults will help clinicians achieve correct diagnoses and better inform patients on the evolution and prognosis. It may also contribute to defining proper outcome measures when testing emerging therapies. ANN NEUROL 2020;87:609-617.

摘要

目的

GM2 神经节苷脂贮积症是由于 HEXA(泰-萨克斯病[TS])或 HEXB(桑德霍夫病[SD])基因的双等位基因突变,导致随后低半乳糖苷酶(s)活性的溶酶体疾病。大多数患者在儿童期发病,但也有一些患者在青少年/成年期首次出现症状。本研究旨在阐明 GM2 神经节苷脂贮积症成年患者的自然史。

方法

我们回顾性描述了来自法国队列的 12 名患者和文献中的 45 名患者。

结果

我们观察到 4 种典型表现:(1)下运动神经元疾病,导致下肢近端肌无力,随后扩展至上肢;(2)小脑共济失调;(3)精神病和/或严重情绪障碍(仅见于 TS 患者);(4)一种混合上述 3 种表现的复杂表型。腰大肌是下肢最早和最易受影响的肌肉,而肱三头肌和骨间肌在上肢中主要受累。复合运动动作电位的纵向研究显示所有神经均进行性下降,其动力学不同。感觉电位有时异常低,主要见于 SD 患者。主要的脑磁共振成像特征是小脑萎缩,即使在没有小脑症状的患者中也是如此。预后主要与步态障碍有关,因为我们发现,在疾病进展超过 20 年后,一半的患者需要使用轮椅。

结论

提高对 GM2 神经节苷脂贮积症成年患者的认识将有助于临床医生做出正确诊断,并更好地告知患者疾病的演变和预后。这也可能有助于在测试新疗法时定义适当的结果衡量标准。神经病学,2020;87:609-617。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验